For: | Rahmi Garcia RM, Rezende PC, Hueb W. Impact of hypoglycemic agents on myocardial ischemic preconditioning. World J Diabetes 2014; 5(3): 258-266 [PMID: 24936247 DOI: 10.4239/wjd.v5.i3.258] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v5/i3/258.htm |
Number | Citing Articles |
1 |
Paulo Cury Rezende, Rosa Maria Rahmi, Whady Hueb. The Influence of Diabetes Mellitus in Myocardial Ischemic Preconditioning. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/8963403
|
2 |
Srikanth Yandrapalli, George Jolly, Adam Horblitt, Gayatri Pemmasani, Abdallah Sanaani, Wilbert S. Aronow, William H. Frishman. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus—Part 1. Cardiology in Review 2020; 28(4): 177 doi: 10.1097/CRD.0000000000000308
|
3 |
N. A. Chernikova, L. L. Kamynina, A. S. Аmetov, D. A. Sychov. The clinical aspects ot the sulphonylurea compounds from the position of the cardioprotective approach at patient with type 2 diabetes, using glucocardiomonitoring. Diabetes mellitus 2022; 25(4): 378 doi: 10.14341/DM12902
|
4 |
Laurentiu M. Pop, Ildiko Lingvay. The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?. Current Diabetes Reports 2017; 17(12) doi: 10.1007/s11892-017-0954-4
|
5 |
Victor Hugo Rezende Duarte, Carolinne Thaisa de Oliveira Fernan Miranda, Marina Sampaio Cruz, Jéssica Nayara Góes de Araújo, Mychelle Kytchia Rodrigues Nunes Duarte, Ayda Maria Quirino Silva dos Santos, Isabelle Cristina Clemente dos Santos, Jéssica Cavalcante dos Santos, Ananília Medeiros Gomes da Silva, Juliana Marinho de Oliveira, Maria Sanali Moura de Oliveira Paiva, Marcos Felipe de Oliveira Galvão, Adriana Augusto Rezende, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata, André Ducati Luchessi, Vivian Nogueira Silbiger. TREML4 mRNA Expression and Polymorphisms in Blood Leukocytes are Associated with Atherosclerotic Lesion Extension in Coronary Artery Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43745-y
|
6 |
Meng-Ting Wang, Ya-Ling Huang, Jyun-Heng Lai, Chien-Hsing Lee, Pin-Chun Wang, Hsueh-Yi Pan, ChenWei Lin, Jun-Ting Liou, Yu-Juei Hsu. Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes. Diabetes Care 2022; 45(5): 1276 doi: 10.2337/dc21-1779
|
7 |
Marwan AL-NİMER, Saeed AL-ZUHAİRY. Antiepileptics pharmacotherapy or antidiabetics may hold potential in treatment of epileptic patients with diabetes mellitus: A narrative review. Hacettepe University Journal of the Faculty of Pharmacy 2023; doi: 10.52794/hujpharm.1198613
|
8 |
Charles E. Leonard, Sean Hennessy, Xu Han, David S. Siscovick, James H. Flory, Rajat Deo. Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. Trends in Endocrinology & Metabolism 2017; 28(8): 561 doi: 10.1016/j.tem.2017.04.003
|
9 |
Paulo Cury Rezende, Rosa Maria Rahmi, Augusto Hiroshi Uchida, Leandro Menezes Alves da Costa, Thiago Luis Scudeler, Cibele Larrosa Garzillo, Eduardo Gomes Lima, Carlos Alexandre Wainrober Segre, Priscyla Girardi, Myrthes Takiuti, Marcela Francisca Silva, Whady Hueb, Jose Antonio Franchini Ramires, Roberto Kalil Filho. Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients. Cardiovascular Diabetology 2015; 14(1) doi: 10.1186/s12933-015-0228-x
|
10 |
S G Khayrullina, R G Sayfutdinov, M V Maleev. Gender differences in effect of ischemic preconditioning in patients with congestive heart failure. Kazan medical journal 2015; 96(3): 341 doi: 10.17750/KMJ2015-341
|